Delivery Order SPE2DB20D2104-SPE2DB25FMWYE
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on July 24, 2025, for 60 tablets of Eliquis 2.5 mg with a ceiling value of $1,989.38. This non-competitive delivery order is set to be completed by July 25, 2025, and represents a pharmaceutical supply requisition under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract award supports the Defense...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,157.96 by the Defense Logistics Agency (DLA) on July 28, 2025, with an ultimate completion date of July 29, 2025. The award is for the supply of Eliquis 5 mg tablets in a 60-count quantity, representing a firm fixed price, competitively awarded delivery order with no set-aside designation. This contract award is executed as a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,186.16 by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is set for July 23, 2025, with performance occurring at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,719.64 by the Defense Logistics Agency (DLA) on July 18, 2025, with completion scheduled for July 21, 2025. The order covers 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication used to reduce stroke risk and treat blood clots. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. Performance will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $16,247.74. The order was competitively awarded without set-aside provisions and has an ultimate completion date of July 23, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60-tablet packages. This firm fixed-price delivery order, valued at $39,593.14, is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,896.80 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a medication used to reduce stroke risk in patients with atrial fibrillation. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWYEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The delivery order, valued at $1,965.60 with a firm fixed price, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a competitive, non-set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The underlying IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. As a child contract under this significant prime vehicle, this delivery order exemplifies the company's critical role in fulfilling federal medical procurement requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/7/25 |